Edwards Lifesciences Corporation Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent
Edwards Lifesciences Corporation (EW) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent of -$20.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-19.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent · last filed 2016-02-19
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2015-12-31 was -$5.70M, a 145.97% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2015-09-30 was -$15.50M, a 165.13% decline year-over-year.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2015-06-30 was -$16.50M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for the quarter ending 2015-03-31 was $17.20M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2015 was -$20.50M, a 171.18% decline from fiscal 2014.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2014 was $28.80M.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2013 was -$3.50M, a 418.18% decline from fiscal 2012.
- Edwards Lifesciences Corporation other comprehensive income (loss), derivatives qualifying as hedges, net of tax, portion attributable to parent for fiscal 2012 was $1.10M, a 93.45% decline from fiscal 2011.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$21.20M derived: sum of 2 quarters · filed 2016-02-19 | -$37.70M derived: sum of 3 quarters · filed 2016-02-19 | -$20.50M 10-K · filed 2016-02-19 |
| 2015-09-30 | -$15.50M 10-Q · filed 2015-10-29 | -$32.00M derived: sum of 2 quarters · filed 2015-10-29 | -$14.80M 10-Q · filed 2015-10-29 | -$2.40M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-06-30 | -$16.50M 10-Q · filed 2015-07-29 | $700.00K 10-Q · filed 2015-07-29 | $13.10M derived: sum of 3 quarters · filed 2016-02-19 | $36.90M derived: sum of 4 quarters · filed 2016-02-19 |
| 2015-03-31 | $17.20M 10-Q · filed 2015-04-29 | $29.60M derived: sum of 2 quarters · filed 2016-02-19 | $53.40M derived: sum of 3 quarters · filed 2016-02-19 | $50.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-12-31 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $36.20M derived: sum of 2 quarters · filed 2016-02-19 | $32.80M derived: sum of 3 quarters · filed 2016-02-19 | $28.80M 10-K · filed 2016-02-19 |
| 2014-09-30 | $23.80M 10-Q · filed 2015-10-29 | $20.40M derived: sum of 2 quarters · filed 2015-10-29 | $16.40M 10-Q · filed 2015-10-29 | $16.30M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$3.40M 10-Q · filed 2015-07-29 | -$7.40M 10-Q · filed 2015-07-29 | -$7.50M derived: sum of 3 quarters · filed 2016-02-19 | -$20.80M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$4.00M 10-Q · filed 2015-04-29 | -$4.10M derived: sum of 2 quarters · filed 2016-02-19 | -$17.40M derived: sum of 3 quarters · filed 2016-02-19 | -$17.60M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$13.40M derived: sum of 2 quarters · filed 2016-02-19 | -$13.60M derived: sum of 3 quarters · filed 2016-02-19 | -$3.50M 10-K · filed 2016-02-19 |
| 2013-09-30 | -$13.30M 10-Q · filed 2014-10-31 | -$13.50M derived: sum of 2 quarters · filed 2014-10-31 | -$3.40M 10-Q · filed 2014-10-31 | -$2.70M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | -$200.00K 10-Q · filed 2014-08-04 | $9.90M 10-Q · filed 2014-08-04 | $10.60M derived: sum of 3 quarters · filed 2015-02-20 | $800.00K derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | $10.10M 10-Q · filed 2014-05-02 | $10.80M derived: sum of 2 quarters · filed 2015-02-20 | $1.00M derived: sum of 3 quarters · filed 2015-02-20 | $6.50M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | -$9.10M derived: sum of 2 quarters · filed 2015-02-20 | -$3.60M derived: sum of 3 quarters · filed 2015-02-20 | $1.10M 10-K · filed 2015-02-20 |
| 2012-09-30 | -$9.80M 10-Q · filed 2013-11-07 | -$4.30M derived: sum of 2 quarters · filed 2013-11-07 | $400.00K 10-Q · filed 2013-11-07 | $9.90M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $5.50M 10-Q · filed 2013-08-06 | $10.20M 10-Q · filed 2013-08-06 | $19.70M derived: sum of 3 quarters · filed 2014-02-28 | $37.20M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $4.70M 10-Q · filed 2013-05-06 | $14.20M derived: sum of 2 quarters · filed 2014-02-28 | $31.70M derived: sum of 3 quarters · filed 2014-02-28 | $28.60M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $27.00M derived: sum of 2 quarters · filed 2014-02-28 | $23.90M derived: sum of 3 quarters · filed 2014-02-28 | $16.80M 10-K · filed 2014-02-28 |
| 2011-09-30 | $17.50M 10-Q · filed 2012-11-07 | $14.40M derived: sum of 2 quarters · filed 2012-11-07 | $7.30M 10-Q · filed 2012-11-07 | $4.20M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | -$3.10M 10-Q · filed 2012-08-07 | -$10.20M 10-Q · filed 2012-08-07 | -$13.30M derived: sum of 3 quarters · filed 2013-02-28 | -$30.80M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | -$7.10M 10-Q · filed 2012-05-09 | -$10.20M derived: sum of 2 quarters · filed 2013-02-28 | -$27.70M derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$20.60M derived: sum of 2 quarters · filed 2013-02-28 | -$6.80M 10-K · filed 2013-02-28 | |
| 2010-09-30 | -$17.50M 10-Q · filed 2011-11-08 | -$3.70M 10-Q · filed 2011-11-08 | ||
| 2009-12-31 | -$3.50M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |